PTCT

PTC Therapeutics, Inc. Press Releases

$56.69
*  
1.73
3.15%
Get PTCT Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading PTCT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Translarna Granted Orphan Drug Designation in the U.S. and Europe for the Treatment of Mucopolysaccharidosis I
12/19/2014 8:00:00 AM - PR Newswire
▲1.69 % Price Change since this news event. The Volume Ratio is 3.31.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12/17/2014 4:30:00 PM - PR Newswire
▲11.42 % Price Change since this news event. The Volume Ratio is 1.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Announces Launch of Translarna™ (ataluren) in Germany
12/3/2014 8:00:00 AM - PR Newswire
▲18.65 % Price Change since this news event. The Volume Ratio is 0.75.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council''s 2014 Legend of Technology Award
11/21/2014 8:00:00 AM - PR Newswire


Spinal Muscular Atrophy Program Enters Phase 1b/2a Trial in Patients with SMA
11/19/2014 8:00:00 AM - PR Newswire


PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11/17/2014 4:30:00 PM - PR Newswire


PTC Therapeutics Appoints Dr. Tuyen Ong SVP, Head of Clinical Development and Translational Research
11/17/2014 8:00:00 AM - PR Newswire


PTC Therapeutics Recognized for Outstanding Innovation at the 2014 Rare & Orphan Advocacy and Research (ROAR) Awards
11/14/2014 8:00:00 AM - PR Newswire
▲37.63 % Price Change since this news event. The Volume Ratio is 0.65.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics to Webcast Upcoming Science Day and Investor Conferences
11/13/2014 5:15:00 PM - PR Newswire
▲37.63 % Price Change since this news event. The Volume Ratio is 0.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
11/6/2014 8:00:00 AM - PR Newswire
▲45.47 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Expands Access For Translarna™ (Ataluren)
11/3/2014 4:30:00 PM - PR Newswire
▲37.20 % Price Change since this news event. The Volume Ratio is 0.5.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics to Present at the Credit Suisse 23rd Annual Healthcare Conference
10/29/2014 8:00:00 AM - PR Newswire
▲37.26 % Price Change since this news event. The Volume Ratio is 1.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Translarna™ Phase 2b Data Published in Muscle & Nerve
10/27/2014 8:00:00 AM - PR Newswire
▲55.53 % Price Change since this news event. The Volume Ratio is 0.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2014 Financial Results
10/23/2014 4:30:00 PM - PR Newswire
▲53.34 % Price Change since this news event. The Volume Ratio is 2.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Announces Pricing of Public Offering of Common Stock
10/9/2014 6:35:00 PM - PR Newswire
▲55.32 % Price Change since this news event. The Volume Ratio is 5.45.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Announces Proposed Public Offering of Common Stock
10/8/2014 4:25:00 PM - PR Newswire
▲43.81 % Price Change since this news event. The Volume Ratio is 1.54.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics to Present at the Leerink Partners Rare Disease Roundtable
9/24/2014 4:35:00 PM - PR Newswire


PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
9/24/2014 4:30:00 PM - PR Newswire